Literature DB >> 11346027

Familial (idiopathic) paroxysmal dyskinesias: an update.

K P Bhatia1.   

Abstract

The clinical, pathophysiological and genetic features of some of the familial (idiopathic) paroxysmal movement disorders are reviewed. The paroxysmal dyskinesias share features and therefore may have the same pathophysiological mechanisms as other episodic neurological disorders which are known to be channelopathies. Paroxysmal kinesigenic choreoathetosis/dyskinesias (PKC/PKD) is a condition in which brief and frequent dyskinetic attacks are provoked by sudden movement. Antiepileptics particularly carbamazepine are very helpful for this condition. PKC has similarities to episodic ataxia type 1 which is caused by mutations of the KCNA1 gene. PKC and a related disorder in which infantile convulsions are associated (ICCA syndrome) have recently been linked to the pericentromic region of chromososme 16 in the vicinity of some ion channel genes. Paroxysmal exercise-induced dystonia (PED) is a rare disorder manifesting as episodes of dystonia mostly affecting the feet induced by continuous exercise like walking or running. The pathophysiology of PED is unknown and antiepileptic drugs are generally unhelpful. In paroxysmal dystonic choreoathetosis/nonkinesigenic dyskinesias (PDC/PNKD) the attacks are of long duration and induced by a variety of factors including coffee, tea, alcohol and fatigue but not by sudden movement. The gene for familial PDC has been linked to chromosome 2q close to a cluster of ion channel genes. Paroxysmal nocturnal dyskinesia is now known to be a form of frontal lobe epilepsy in some cases which may be familial with an autosomal dominant inheritance and has been given the eponym ADNFLE. ADNFLE is a genetically heterogenous condition. Mutations of the neuronal nicotinic acetylcholine receptor gene that have chromosome 20q have been reported in some families with ADNFLE. However, another family with ADNFLE has been linked to chromosome 15 in the area of another nicotinic acetylcholine receptor gene. Thus the familial paroxysmal dyskinesias appear to be clinically and genetically heterogeneous.

Entities:  

Mesh:

Year:  2001        PMID: 11346027     DOI: 10.1055/s-2001-13121

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  18 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.

Authors:  Veronique Michel; Florence Riant; Elisabeth Tournier-Lasserve; Dominique Guehl; Alain Lagueny; Bernard Bioulac; Pierre Burbaud
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

3.  Paroxysmal non-kinesigenic dyskinesia, post-streptococcal syndromes and psychogenic movement disorders: a diagnostic challenge.

Authors:  Elena Peila; Paolo Mortara; Alessandro Cicerale; Lorenzo Pinessi
Journal:  BMJ Case Rep       Date:  2015-03-20

Review 4.  Animal models of generalized dystonia.

Authors:  Robert S Raike; H A Jinnah; Ellen J Hess
Journal:  NeuroRx       Date:  2005-07

5.  GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.

Authors:  Yvonne G Weber; Alexander Storch; Thomas V Wuttke; Knut Brockmann; Judith Kempfle; Snezana Maljevic; Lucia Margari; Christoph Kamm; Susanne A Schneider; Stephan M Huber; Arnulf Pekrun; Robert Roebling; Guiscard Seebohm; Saisudha Koka; Camelia Lang; Eduard Kraft; Dragica Blazevic; Alberto Salvo-Vargas; Michael Fauler; Felix M Mottaghy; Alexander Münchau; Mark J Edwards; Anna Presicci; Francesco Margari; Thomas Gasser; Florian Lang; Kailash P Bhatia; Frank Lehmann-Horn; Holger Lerche
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 6.  The clinical approach to movement disorders.

Authors:  Wilson F Abdo; Bart P C van de Warrenburg; David J Burn; Niall P Quinn; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2010-01       Impact factor: 42.937

7.  Stress, caffeine and ethanol trigger transient neurological dysfunction through shared mechanisms in a mouse calcium channelopathy.

Authors:  Robert S Raike; Catherine Weisz; Freek E Hoebeek; Matthew C Terzi; Chris I De Zeeuw; Arn M van den Maagdenberg; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2012-09-23       Impact factor: 5.996

8.  Clinical characteristics of paroxysmal kinesigenic choreoathetosis: diagnosis, treatment and prognosis.

Authors:  Huicong Kang; Qi Hu; Xiaoyan Liu; Feng Xu; Lin Chen; Suiqiang Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

9.  Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Authors:  Josua Kegele; Johanna Krüger; Mahmoud Koko; Lara Lange; Ana Victoria Marco Hernandez; Francisco Martinez; Alexander Münchau; Holger Lerche; Stephan Lauxmann
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

10.  Paroxysmal hypnogenic dyskinesia responsive to doxylamine: a case report.

Authors:  Daniel M Williams
Journal:  Case Rep Neurol Med       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.